nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—Pyruvic acid—PC—hematologic cancer	0.00827	0.725	CrCbGaD
Acetylcysteine—CHUK—hematopoietic system—hematologic cancer	0.0073	0.0723	CbGeAlD
Acetylcysteine—ACY1—lung—hematologic cancer	0.00615	0.0609	CbGeAlD
Acetylcysteine—ACY1—testis—hematologic cancer	0.0058	0.0574	CbGeAlD
Acetylcysteine—IKBKB—hematopoietic system—hematologic cancer	0.00497	0.0492	CbGeAlD
Acetylcysteine—GSS—hematopoietic system—hematologic cancer	0.00487	0.0483	CbGeAlD
Acetylcysteine—CHUK—blood—hematologic cancer	0.00484	0.0479	CbGeAlD
Acetylcysteine—CHUK—lung—hematologic cancer	0.00424	0.042	CbGeAlD
Acetylcysteine—GRIN2D—testis—hematologic cancer	0.00411	0.0407	CbGeAlD
Acetylcysteine—CHUK—testis—hematologic cancer	0.004	0.0396	CbGeAlD
Acetylcysteine—GRIN3A—testis—hematologic cancer	0.00386	0.0382	CbGeAlD
Acetylcysteine—IKBKB—gonad—hematologic cancer	0.00378	0.0374	CbGeAlD
Acetylcysteine—GSS—gonad—hematologic cancer	0.00371	0.0367	CbGeAlD
Acetylcysteine—SLCO1B1—hematopoietic system—hematologic cancer	0.00358	0.0355	CbGeAlD
Acetylcysteine—SLC7A11—lung—hematologic cancer	0.00349	0.0346	CbGeAlD
Acetylcysteine—SLC7A11—testis—hematologic cancer	0.0033	0.0326	CbGeAlD
Acetylcysteine—IKBKB—blood—hematologic cancer	0.00329	0.0326	CbGeAlD
Acetylcysteine—GSS—blood—hematologic cancer	0.00323	0.032	CbGeAlD
Acetylcysteine—L-Cysteine—MGMT—hematologic cancer	0.00314	0.275	CrCbGaD
Acetylcysteine—GSS—bone marrow—hematologic cancer	0.00312	0.0309	CbGeAlD
Acetylcysteine—GRIN2A—testis—hematologic cancer	0.00305	0.0302	CbGeAlD
Acetylcysteine—CHUK—lymph node—hematologic cancer	0.0029	0.0287	CbGeAlD
Acetylcysteine—IKBKB—lung—hematologic cancer	0.00288	0.0286	CbGeAlD
Acetylcysteine—GSS—lung—hematologic cancer	0.00283	0.028	CbGeAlD
Acetylcysteine—IKBKB—testis—hematologic cancer	0.00272	0.0269	CbGeAlD
Acetylcysteine—GSS—testis—hematologic cancer	0.00267	0.0264	CbGeAlD
Acetylcysteine—SLCO1B1—blood—hematologic cancer	0.00237	0.0235	CbGeAlD
Acetylcysteine—IKBKB—lymph node—hematologic cancer	0.00197	0.0195	CbGeAlD
Acetylcysteine—GSS—lymph node—hematologic cancer	0.00194	0.0192	CbGeAlD
Acetylcysteine—SLC7A11—Betamethasone—Dexamethasone—hematologic cancer	0.000665	0.131	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Betamethasone—hematologic cancer	0.000665	0.131	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Triamcinolone—hematologic cancer	0.000649	0.128	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Triamcinolone—hematologic cancer	0.000649	0.128	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisone—hematologic cancer	0.000616	0.122	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisone—hematologic cancer	0.000616	0.122	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Prednisolone—hematologic cancer	0.000602	0.119	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisolone—hematologic cancer	0.000602	0.119	CbGdCrCtD
Acetylcysteine—Angioedema—Betamethasone—hematologic cancer	0.000168	0.000394	CcSEcCtD
Acetylcysteine—Dizziness—Thiotepa—hematologic cancer	0.000168	0.000393	CcSEcCtD
Acetylcysteine—Rash—Vinorelbine—hematologic cancer	0.000168	0.000393	CcSEcCtD
Acetylcysteine—Dermatitis—Vinorelbine—hematologic cancer	0.000168	0.000392	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—hematologic cancer	0.000167	0.000391	CcSEcCtD
Acetylcysteine—Angiopathy—Prednisone—hematologic cancer	0.000167	0.000391	CcSEcCtD
Acetylcysteine—Asthma—Doxorubicin—hematologic cancer	0.000167	0.00039	CcSEcCtD
Acetylcysteine—Immune system disorder—Prednisone—hematologic cancer	0.000166	0.000389	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vincristine—hematologic cancer	0.000166	0.000389	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Triamcinolone—hematologic cancer	0.000166	0.000388	CcSEcCtD
Acetylcysteine—Oedema—Triamcinolone—hematologic cancer	0.000166	0.000388	CcSEcCtD
Acetylcysteine—Pruritus—Alitretinoin—hematologic cancer	0.000165	0.000387	CcSEcCtD
Acetylcysteine—Syncope—Betamethasone—hematologic cancer	0.000165	0.000386	CcSEcCtD
Acetylcysteine—Syncope—Dexamethasone—hematologic cancer	0.000165	0.000386	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—hematologic cancer	0.000164	0.000385	CcSEcCtD
Acetylcysteine—Pruritus—Ifosfamide—hematologic cancer	0.000164	0.000383	CcSEcCtD
Acetylcysteine—Shock—Triamcinolone—hematologic cancer	0.000163	0.000381	CcSEcCtD
Acetylcysteine—Dyspnoea—Etoposide—hematologic cancer	0.000163	0.000381	CcSEcCtD
Acetylcysteine—Dizziness—Thalidomide—hematologic cancer	0.000163	0.00038	CcSEcCtD
Acetylcysteine—Somnolence—Etoposide—hematologic cancer	0.000162	0.00038	CcSEcCtD
Acetylcysteine—Nausea—Bortezomib—hematologic cancer	0.000162	0.000379	CcSEcCtD
Acetylcysteine—Loss of consciousness—Dexamethasone—hematologic cancer	0.000162	0.000379	CcSEcCtD
Acetylcysteine—Loss of consciousness—Betamethasone—hematologic cancer	0.000162	0.000379	CcSEcCtD
Acetylcysteine—Hypersensitivity—Mitoxantrone—hematologic cancer	0.000162	0.000379	CcSEcCtD
Acetylcysteine—Hypersensitivity—Irinotecan—hematologic cancer	0.000162	0.000379	CcSEcCtD
Acetylcysteine—Tachycardia—Triamcinolone—hematologic cancer	0.000162	0.000378	CcSEcCtD
Acetylcysteine—Vomiting—Thiotepa—hematologic cancer	0.000162	0.000378	CcSEcCtD
Acetylcysteine—Nausea—Bleomycin—hematologic cancer	0.000161	0.000376	CcSEcCtD
Acetylcysteine—Drowsiness—Epirubicin—hematologic cancer	0.00016	0.000376	CcSEcCtD
Acetylcysteine—Erythema—Prednisone—hematologic cancer	0.00016	0.000375	CcSEcCtD
Acetylcysteine—Rash—Thiotepa—hematologic cancer	0.00016	0.000375	CcSEcCtD
Acetylcysteine—Dermatitis—Thiotepa—hematologic cancer	0.00016	0.000375	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Triamcinolone—hematologic cancer	0.00016	0.000375	CcSEcCtD
Acetylcysteine—Nausea—Vinorelbine—hematologic cancer	0.000158	0.00037	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000158	0.000369	CcSEcCtD
Acetylcysteine—Body temperature increased—Cisplatin—hematologic cancer	0.000158	0.000369	CcSEcCtD
Acetylcysteine—Stomatitis—Epirubicin—hematologic cancer	0.000156	0.000366	CcSEcCtD
Acetylcysteine—Vomiting—Thalidomide—hematologic cancer	0.000156	0.000366	CcSEcCtD
Acetylcysteine—Dizziness—Carmustine—hematologic cancer	0.000156	0.000365	CcSEcCtD
Acetylcysteine—Rash—Thalidomide—hematologic cancer	0.000155	0.000363	CcSEcCtD
Acetylcysteine—Dermatitis—Thalidomide—hematologic cancer	0.000155	0.000362	CcSEcCtD
Acetylcysteine—Dizziness—Alitretinoin—hematologic cancer	0.000155	0.000362	CcSEcCtD
Acetylcysteine—Sweating—Epirubicin—hematologic cancer	0.000154	0.00036	CcSEcCtD
Acetylcysteine—Dizziness—Ifosfamide—hematologic cancer	0.000153	0.000358	CcSEcCtD
Acetylcysteine—Pharyngitis—Methotrexate—hematologic cancer	0.000153	0.000358	CcSEcCtD
Acetylcysteine—Pruritus—Gemcitabine—hematologic cancer	0.000151	0.000354	CcSEcCtD
Acetylcysteine—Nausea—Thiotepa—hematologic cancer	0.000151	0.000353	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.00015	0.000352	CcSEcCtD
Acetylcysteine—Oedema—Dexamethasone—hematologic cancer	0.00015	0.000352	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Betamethasone—hematologic cancer	0.00015	0.000352	CcSEcCtD
Acetylcysteine—Oedema—Betamethasone—hematologic cancer	0.00015	0.000352	CcSEcCtD
Acetylcysteine—Vomiting—Carmustine—hematologic cancer	0.00015	0.000351	CcSEcCtD
Acetylcysteine—Dizziness—Vincristine—hematologic cancer	0.000149	0.000349	CcSEcCtD
Acetylcysteine—Rash—Carmustine—hematologic cancer	0.000149	0.000348	CcSEcCtD
Acetylcysteine—Dermatitis—Carmustine—hematologic cancer	0.000149	0.000348	CcSEcCtD
Acetylcysteine—Vomiting—Alitretinoin—hematologic cancer	0.000149	0.000348	CcSEcCtD
Acetylcysteine—Drowsiness—Doxorubicin—hematologic cancer	0.000148	0.000348	CcSEcCtD
Acetylcysteine—Shock—Dexamethasone—hematologic cancer	0.000148	0.000346	CcSEcCtD
Acetylcysteine—Shock—Betamethasone—hematologic cancer	0.000148	0.000346	CcSEcCtD
Acetylcysteine—Dyspnoea—Triamcinolone—hematologic cancer	0.000148	0.000346	CcSEcCtD
Acetylcysteine—Rash—Alitretinoin—hematologic cancer	0.000147	0.000345	CcSEcCtD
Acetylcysteine—Dermatitis—Alitretinoin—hematologic cancer	0.000147	0.000345	CcSEcCtD
Acetylcysteine—Vomiting—Ifosfamide—hematologic cancer	0.000147	0.000344	CcSEcCtD
Acetylcysteine—Hypersensitivity—Cisplatin—hematologic cancer	0.000147	0.000344	CcSEcCtD
Acetylcysteine—Tachycardia—Dexamethasone—hematologic cancer	0.000147	0.000343	CcSEcCtD
Acetylcysteine—Tachycardia—Betamethasone—hematologic cancer	0.000147	0.000343	CcSEcCtD
Acetylcysteine—Angioedema—Prednisone—hematologic cancer	0.000147	0.000343	CcSEcCtD
Acetylcysteine—Nausea—Thalidomide—hematologic cancer	0.000146	0.000342	CcSEcCtD
Acetylcysteine—Dyspepsia—Triamcinolone—hematologic cancer	0.000146	0.000341	CcSEcCtD
Acetylcysteine—Rash—Ifosfamide—hematologic cancer	0.000146	0.000341	CcSEcCtD
Acetylcysteine—Dermatitis—Ifosfamide—hematologic cancer	0.000146	0.000341	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000145	0.00034	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000145	0.00034	CcSEcCtD
Acetylcysteine—Dizziness—Irinotecan—hematologic cancer	0.000145	0.00034	CcSEcCtD
Acetylcysteine—Urticaria—Etoposide—hematologic cancer	0.000145	0.000339	CcSEcCtD
Acetylcysteine—Stomatitis—Doxorubicin—hematologic cancer	0.000145	0.000339	CcSEcCtD
Acetylcysteine—Body temperature increased—Etoposide—hematologic cancer	0.000144	0.000338	CcSEcCtD
Acetylcysteine—Syncope—Prednisone—hematologic cancer	0.000144	0.000337	CcSEcCtD
Acetylcysteine—Vomiting—Vincristine—hematologic cancer	0.000143	0.000335	CcSEcCtD
Acetylcysteine—Urticaria—Prednisolone—hematologic cancer	0.000143	0.000335	CcSEcCtD
Acetylcysteine—Pharyngitis—Epirubicin—hematologic cancer	0.000143	0.000335	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—hematologic cancer	0.000143	0.000334	CcSEcCtD
Acetylcysteine—Sweating—Doxorubicin—hematologic cancer	0.000142	0.000333	CcSEcCtD
Acetylcysteine—Rash—Vincristine—hematologic cancer	0.000142	0.000333	CcSEcCtD
Acetylcysteine—Dermatitis—Vincristine—hematologic cancer	0.000142	0.000332	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisone—hematologic cancer	0.000141	0.00033	CcSEcCtD
Acetylcysteine—Hypotension—Dexamethasone—hematologic cancer	0.00014	0.000329	CcSEcCtD
Acetylcysteine—Hypotension—Betamethasone—hematologic cancer	0.00014	0.000329	CcSEcCtD
Acetylcysteine—Nausea—Carmustine—hematologic cancer	0.00014	0.000328	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—hematologic cancer	0.00014	0.000327	CcSEcCtD
Acetylcysteine—Vomiting—Mitoxantrone—hematologic cancer	0.00014	0.000327	CcSEcCtD
Acetylcysteine—Vomiting—Irinotecan—hematologic cancer	0.00014	0.000327	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—hematologic cancer	0.000139	0.000325	CcSEcCtD
Acetylcysteine—Nausea—Alitretinoin—hematologic cancer	0.000139	0.000325	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—hematologic cancer	0.000139	0.000325	CcSEcCtD
Acetylcysteine—Rash—Irinotecan—hematologic cancer	0.000138	0.000324	CcSEcCtD
Acetylcysteine—Rash—Mitoxantrone—hematologic cancer	0.000138	0.000324	CcSEcCtD
Acetylcysteine—Dermatitis—Mitoxantrone—hematologic cancer	0.000138	0.000324	CcSEcCtD
Acetylcysteine—Dermatitis—Irinotecan—hematologic cancer	0.000138	0.000324	CcSEcCtD
Acetylcysteine—Nausea—Ifosfamide—hematologic cancer	0.000137	0.000321	CcSEcCtD
Acetylcysteine—Vomiting—Gemcitabine—hematologic cancer	0.000136	0.000318	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000136	0.000317	CcSEcCtD
Acetylcysteine—Rash—Gemcitabine—hematologic cancer	0.000135	0.000316	CcSEcCtD
Acetylcysteine—Dermatitis—Gemcitabine—hematologic cancer	0.000135	0.000315	CcSEcCtD
Acetylcysteine—Hypersensitivity—Etoposide—hematologic cancer	0.000135	0.000315	CcSEcCtD
Acetylcysteine—Erythema—Methotrexate—hematologic cancer	0.000134	0.000314	CcSEcCtD
Acetylcysteine—Nausea—Vincristine—hematologic cancer	0.000134	0.000313	CcSEcCtD
Acetylcysteine—Flushing—Epirubicin—hematologic cancer	0.000134	0.000313	CcSEcCtD
Acetylcysteine—Cardiac disorder—Epirubicin—hematologic cancer	0.000134	0.000313	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisolone—hematologic cancer	0.000133	0.000311	CcSEcCtD
Acetylcysteine—Pharyngitis—Doxorubicin—hematologic cancer	0.000132	0.00031	CcSEcCtD
Acetylcysteine—Dyspepsia—Dexamethasone—hematologic cancer	0.000132	0.00031	CcSEcCtD
Acetylcysteine—Dyspepsia—Betamethasone—hematologic cancer	0.000132	0.00031	CcSEcCtD
Acetylcysteine—Urticaria—Triamcinolone—hematologic cancer	0.000132	0.000308	CcSEcCtD
Acetylcysteine—Body temperature increased—Triamcinolone—hematologic cancer	0.000131	0.000306	CcSEcCtD
Acetylcysteine—Oedema—Prednisone—hematologic cancer	0.000131	0.000306	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisone—hematologic cancer	0.000131	0.000306	CcSEcCtD
Acetylcysteine—Angiopathy—Epirubicin—hematologic cancer	0.000131	0.000306	CcSEcCtD
Acetylcysteine—Nausea—Irinotecan—hematologic cancer	0.00013	0.000305	CcSEcCtD
Acetylcysteine—Nausea—Mitoxantrone—hematologic cancer	0.00013	0.000305	CcSEcCtD
Acetylcysteine—Immune system disorder—Epirubicin—hematologic cancer	0.00013	0.000305	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Epirubicin—hematologic cancer	0.00013	0.000304	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.00013	0.000304	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.00013	0.000304	CcSEcCtD
Acetylcysteine—Pruritus—Etoposide—hematologic cancer	0.000129	0.000302	CcSEcCtD
Acetylcysteine—Shock—Prednisone—hematologic cancer	0.000129	0.000301	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisone—hematologic cancer	0.000128	0.000299	CcSEcCtD
Acetylcysteine—Skin disorder—Prednisone—hematologic cancer	0.000127	0.000297	CcSEcCtD
Acetylcysteine—Nausea—Gemcitabine—hematologic cancer	0.000127	0.000297	CcSEcCtD
Acetylcysteine—Vomiting—Cisplatin—hematologic cancer	0.000127	0.000297	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisone—hematologic cancer	0.000127	0.000296	CcSEcCtD
Acetylcysteine—Rash—Cisplatin—hematologic cancer	0.000126	0.000294	CcSEcCtD
Acetylcysteine—Dermatitis—Cisplatin—hematologic cancer	0.000126	0.000294	CcSEcCtD
Acetylcysteine—Erythema—Epirubicin—hematologic cancer	0.000125	0.000294	CcSEcCtD
Acetylcysteine—Cardiac disorder—Doxorubicin—hematologic cancer	0.000124	0.00029	CcSEcCtD
Acetylcysteine—Flushing—Doxorubicin—hematologic cancer	0.000124	0.00029	CcSEcCtD
Acetylcysteine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000122	0.000286	CcSEcCtD
Acetylcysteine—Angiopathy—Doxorubicin—hematologic cancer	0.000121	0.000283	CcSEcCtD
Acetylcysteine—Dizziness—Etoposide—hematologic cancer	0.000121	0.000283	CcSEcCtD
Acetylcysteine—Immune system disorder—Doxorubicin—hematologic cancer	0.00012	0.000282	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Doxorubicin—hematologic cancer	0.00012	0.000281	CcSEcCtD
Acetylcysteine—Urticaria—Dexamethasone—hematologic cancer	0.000119	0.000279	CcSEcCtD
Acetylcysteine—Urticaria—Betamethasone—hematologic cancer	0.000119	0.000279	CcSEcCtD
Acetylcysteine—Dizziness—Prednisolone—hematologic cancer	0.000119	0.000279	CcSEcCtD
Acetylcysteine—Body temperature increased—Dexamethasone—hematologic cancer	0.000119	0.000278	CcSEcCtD
Acetylcysteine—Body temperature increased—Betamethasone—hematologic cancer	0.000119	0.000278	CcSEcCtD
Acetylcysteine—Nausea—Cisplatin—hematologic cancer	0.000118	0.000277	CcSEcCtD
Acetylcysteine—Pruritus—Triamcinolone—hematologic cancer	0.000117	0.000274	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—hematologic cancer	0.000117	0.000274	CcSEcCtD
Acetylcysteine—Vomiting—Etoposide—hematologic cancer	0.000116	0.000272	CcSEcCtD
Acetylcysteine—Erythema—Doxorubicin—hematologic cancer	0.000116	0.000272	CcSEcCtD
Acetylcysteine—Dyspepsia—Prednisone—hematologic cancer	0.000115	0.00027	CcSEcCtD
Acetylcysteine—Rash—Etoposide—hematologic cancer	0.000115	0.000269	CcSEcCtD
Acetylcysteine—Dermatitis—Etoposide—hematologic cancer	0.000115	0.000269	CcSEcCtD
Acetylcysteine—Rash—Prednisolone—hematologic cancer	0.000114	0.000266	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisolone—hematologic cancer	0.000113	0.000266	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000113	0.000265	CcSEcCtD
Acetylcysteine—Syncope—Epirubicin—hematologic cancer	0.000112	0.000263	CcSEcCtD
Acetylcysteine—Loss of consciousness—Epirubicin—hematologic cancer	0.00011	0.000258	CcSEcCtD
Acetylcysteine—Dizziness—Triamcinolone—hematologic cancer	0.00011	0.000256	CcSEcCtD
Acetylcysteine—Cough—Epirubicin—hematologic cancer	0.000109	0.000256	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000109	0.000256	CcSEcCtD
Acetylcysteine—Nausea—Etoposide—hematologic cancer	0.000108	0.000254	CcSEcCtD
Acetylcysteine—Nausea—Prednisolone—hematologic cancer	0.000107	0.00025	CcSEcCtD
Acetylcysteine—Pruritus—Betamethasone—hematologic cancer	0.000106	0.000249	CcSEcCtD
Acetylcysteine—Pruritus—Dexamethasone—hematologic cancer	0.000106	0.000249	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—hematologic cancer	0.000106	0.000249	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000106	0.000248	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000106	0.000247	CcSEcCtD
Acetylcysteine—Vomiting—Triamcinolone—hematologic cancer	0.000105	0.000246	CcSEcCtD
Acetylcysteine—Rash—Triamcinolone—hematologic cancer	0.000104	0.000244	CcSEcCtD
Acetylcysteine—Dermatitis—Triamcinolone—hematologic cancer	0.000104	0.000244	CcSEcCtD
Acetylcysteine—Syncope—Doxorubicin—hematologic cancer	0.000104	0.000244	CcSEcCtD
Acetylcysteine—Urticaria—Prednisone—hematologic cancer	0.000104	0.000243	CcSEcCtD
Acetylcysteine—Body temperature increased—Prednisone—hematologic cancer	0.000103	0.000242	CcSEcCtD
Acetylcysteine—Oedema—Epirubicin—hematologic cancer	0.000102	0.00024	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000102	0.00024	CcSEcCtD
Acetylcysteine—Hypotension—Methotrexate—hematologic cancer	0.000102	0.000239	CcSEcCtD
Acetylcysteine—Loss of consciousness—Doxorubicin—hematologic cancer	0.000102	0.000239	CcSEcCtD
Acetylcysteine—Cough—Doxorubicin—hematologic cancer	0.000101	0.000237	CcSEcCtD
Acetylcysteine—Shock—Epirubicin—hematologic cancer	0.000101	0.000236	CcSEcCtD
Acetylcysteine—Tachycardia—Epirubicin—hematologic cancer	9.99e-05	0.000234	CcSEcCtD
Acetylcysteine—Skin disorder—Epirubicin—hematologic cancer	9.94e-05	0.000233	CcSEcCtD
Acetylcysteine—Dizziness—Dexamethasone—hematologic cancer	9.94e-05	0.000233	CcSEcCtD
Acetylcysteine—Dizziness—Betamethasone—hematologic cancer	9.94e-05	0.000233	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Epirubicin—hematologic cancer	9.89e-05	0.000232	CcSEcCtD
Acetylcysteine—Nausea—Triamcinolone—hematologic cancer	9.84e-05	0.00023	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	9.81e-05	0.00023	CcSEcCtD
Acetylcysteine—Dyspnoea—Methotrexate—hematologic cancer	9.75e-05	0.000228	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—hematologic cancer	9.72e-05	0.000228	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisone—hematologic cancer	9.64e-05	0.000226	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—hematologic cancer	9.63e-05	0.000225	CcSEcCtD
Acetylcysteine—Hypotension—Epirubicin—hematologic cancer	9.56e-05	0.000224	CcSEcCtD
Acetylcysteine—Vomiting—Dexamethasone—hematologic cancer	9.55e-05	0.000224	CcSEcCtD
Acetylcysteine—Vomiting—Betamethasone—hematologic cancer	9.55e-05	0.000224	CcSEcCtD
Acetylcysteine—Rash—Dexamethasone—hematologic cancer	9.47e-05	0.000222	CcSEcCtD
Acetylcysteine—Rash—Betamethasone—hematologic cancer	9.47e-05	0.000222	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Doxorubicin—hematologic cancer	9.47e-05	0.000222	CcSEcCtD
Acetylcysteine—Oedema—Doxorubicin—hematologic cancer	9.47e-05	0.000222	CcSEcCtD
Acetylcysteine—Dermatitis—Betamethasone—hematologic cancer	9.47e-05	0.000222	CcSEcCtD
Acetylcysteine—Dermatitis—Dexamethasone—hematologic cancer	9.47e-05	0.000222	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—hematologic cancer	9.44e-05	0.000221	CcSEcCtD
Acetylcysteine—Shock—Doxorubicin—hematologic cancer	9.32e-05	0.000218	CcSEcCtD
Acetylcysteine—Pruritus—Prednisone—hematologic cancer	9.26e-05	0.000217	CcSEcCtD
Acetylcysteine—Tachycardia—Doxorubicin—hematologic cancer	9.24e-05	0.000216	CcSEcCtD
Acetylcysteine—Skin disorder—Doxorubicin—hematologic cancer	9.2e-05	0.000215	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Doxorubicin—hematologic cancer	9.15e-05	0.000214	CcSEcCtD
Acetylcysteine—Dyspnoea—Epirubicin—hematologic cancer	9.12e-05	0.000214	CcSEcCtD
Acetylcysteine—Somnolence—Epirubicin—hematologic cancer	9.1e-05	0.000213	CcSEcCtD
Acetylcysteine—Dyspepsia—Epirubicin—hematologic cancer	9.01e-05	0.000211	CcSEcCtD
Acetylcysteine—Nausea—Dexamethasone—hematologic cancer	8.93e-05	0.000209	CcSEcCtD
Acetylcysteine—Nausea—Betamethasone—hematologic cancer	8.93e-05	0.000209	CcSEcCtD
Acetylcysteine—Hypotension—Doxorubicin—hematologic cancer	8.85e-05	0.000207	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Epirubicin—hematologic cancer	8.84e-05	0.000207	CcSEcCtD
Acetylcysteine—Urticaria—Methotrexate—hematologic cancer	8.69e-05	0.000203	CcSEcCtD
Acetylcysteine—Dizziness—Prednisone—hematologic cancer	8.65e-05	0.000203	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—hematologic cancer	8.65e-05	0.000202	CcSEcCtD
Acetylcysteine—Dyspnoea—Doxorubicin—hematologic cancer	8.44e-05	0.000198	CcSEcCtD
Acetylcysteine—Somnolence—Doxorubicin—hematologic cancer	8.42e-05	0.000197	CcSEcCtD
Acetylcysteine—Dyspepsia—Doxorubicin—hematologic cancer	8.34e-05	0.000195	CcSEcCtD
Acetylcysteine—Vomiting—Prednisone—hematologic cancer	8.32e-05	0.000195	CcSEcCtD
Acetylcysteine—Rash—Prednisone—hematologic cancer	8.25e-05	0.000193	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisone—hematologic cancer	8.24e-05	0.000193	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	8.18e-05	0.000191	CcSEcCtD
Acetylcysteine—Urticaria—Epirubicin—hematologic cancer	8.13e-05	0.00019	CcSEcCtD
Acetylcysteine—Body temperature increased—Epirubicin—hematologic cancer	8.09e-05	0.000189	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methotrexate—hematologic cancer	8.06e-05	0.000189	CcSEcCtD
Acetylcysteine—Nausea—Prednisone—hematologic cancer	7.77e-05	0.000182	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—hematologic cancer	7.74e-05	0.000181	CcSEcCtD
Acetylcysteine—Hypersensitivity—Epirubicin—hematologic cancer	7.54e-05	0.000176	CcSEcCtD
Acetylcysteine—Urticaria—Doxorubicin—hematologic cancer	7.52e-05	0.000176	CcSEcCtD
Acetylcysteine—Body temperature increased—Doxorubicin—hematologic cancer	7.49e-05	0.000175	CcSEcCtD
Acetylcysteine—Pruritus—Epirubicin—hematologic cancer	7.24e-05	0.000169	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—hematologic cancer	7.23e-05	0.000169	CcSEcCtD
Acetylcysteine—Hypersensitivity—Doxorubicin—hematologic cancer	6.98e-05	0.000163	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—hematologic cancer	6.95e-05	0.000163	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—hematologic cancer	6.9e-05	0.000161	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—hematologic cancer	6.89e-05	0.000161	CcSEcCtD
Acetylcysteine—Dizziness—Epirubicin—hematologic cancer	6.77e-05	0.000158	CcSEcCtD
Acetylcysteine—Pruritus—Doxorubicin—hematologic cancer	6.7e-05	0.000157	CcSEcCtD
Acetylcysteine—Vomiting—Epirubicin—hematologic cancer	6.51e-05	0.000152	CcSEcCtD
Acetylcysteine—Nausea—Methotrexate—hematologic cancer	6.5e-05	0.000152	CcSEcCtD
Acetylcysteine—Rash—Epirubicin—hematologic cancer	6.45e-05	0.000151	CcSEcCtD
Acetylcysteine—Dermatitis—Epirubicin—hematologic cancer	6.45e-05	0.000151	CcSEcCtD
Acetylcysteine—Dizziness—Doxorubicin—hematologic cancer	6.26e-05	0.000147	CcSEcCtD
Acetylcysteine—Nausea—Epirubicin—hematologic cancer	6.08e-05	0.000142	CcSEcCtD
Acetylcysteine—Vomiting—Doxorubicin—hematologic cancer	6.02e-05	0.000141	CcSEcCtD
Acetylcysteine—Rash—Doxorubicin—hematologic cancer	5.97e-05	0.00014	CcSEcCtD
Acetylcysteine—Dermatitis—Doxorubicin—hematologic cancer	5.97e-05	0.00014	CcSEcCtD
Acetylcysteine—Nausea—Doxorubicin—hematologic cancer	5.62e-05	0.000132	CcSEcCtD
Acetylcysteine—IKBKB—Immune System—PTPN11—hematologic cancer	8.11e-06	1.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CD86—hematologic cancer	8.08e-06	1.78e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAP2K1—hematologic cancer	8.06e-06	1.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—NRAS—hematologic cancer	8.04e-06	1.77e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK3—hematologic cancer	8.02e-06	1.76e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CD—hematologic cancer	8e-06	1.76e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CREB1—hematologic cancer	8e-06	1.76e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HES1—hematologic cancer	7.97e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GRB2—hematologic cancer	7.96e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—hematologic cancer	7.95e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NCOR1—hematologic cancer	7.95e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—KRAS—hematologic cancer	7.95e-06	1.75e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFA—hematologic cancer	7.94e-06	1.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NCOR1—hematologic cancer	7.93e-06	1.74e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—BRAF—hematologic cancer	7.9e-06	1.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FOS—hematologic cancer	7.87e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CREB1—hematologic cancer	7.86e-06	1.73e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGF1—hematologic cancer	7.84e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CSF2—hematologic cancer	7.84e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KITLG—hematologic cancer	7.82e-06	1.72e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6R—hematologic cancer	7.81e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CREBBP—hematologic cancer	7.79e-06	1.71e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FOXO1—hematologic cancer	7.73e-06	1.7e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFRB—hematologic cancer	7.71e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CASP8—hematologic cancer	7.69e-06	1.69e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6R—hematologic cancer	7.67e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—FGF2—hematologic cancer	7.66e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CREBBP—hematologic cancer	7.66e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT5A—hematologic cancer	7.65e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KRAS—hematologic cancer	7.63e-06	1.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFRA—hematologic cancer	7.59e-06	1.67e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN2B—hematologic cancer	7.58e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JAK1—hematologic cancer	7.57e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PRKCG—hematologic cancer	7.57e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3R1—hematologic cancer	7.56e-06	1.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAP2K1—hematologic cancer	7.44e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—hematologic cancer	7.41e-06	1.63e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CD—hematologic cancer	7.39e-06	1.62e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JAK2—hematologic cancer	7.35e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CD86—hematologic cancer	7.33e-06	1.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAP2K1—hematologic cancer	7.31e-06	1.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—hematologic cancer	7.3e-06	1.6e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2—hematologic cancer	7.28e-06	1.6e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CD—hematologic cancer	7.26e-06	1.59e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HES1—hematologic cancer	7.23e-06	1.59e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IFNG—hematologic cancer	7.21e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—KRAS—hematologic cancer	7.21e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NCOR1—hematologic cancer	7.19e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MDM2—hematologic cancer	7.17e-06	1.58e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CSF2—hematologic cancer	7.11e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGF1—hematologic cancer	7.11e-06	1.56e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—FGF2—hematologic cancer	7.08e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2RA—hematologic cancer	7.07e-06	1.55e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—MTHFR—hematologic cancer	7.03e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—hematologic cancer	7.01e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FOXO1—hematologic cancer	7.01e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFRB—hematologic cancer	6.99e-06	1.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TERT—hematologic cancer	6.99e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3R1—hematologic cancer	6.98e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MTOR—hematologic cancer	6.98e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CB—hematologic cancer	6.98e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD4—hematologic cancer	6.96e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—FGF2—hematologic cancer	6.95e-06	1.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KRAS—hematologic cancer	6.92e-06	1.52e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFRA—hematologic cancer	6.88e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JAK1—hematologic cancer	6.86e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PRKCG—hematologic cancer	6.86e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3R1—hematologic cancer	6.85e-06	1.51e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PDGFB—hematologic cancer	6.82e-06	1.5e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—JAK2—hematologic cancer	6.78e-06	1.49e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—hematologic cancer	6.76e-06	1.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TSC2—hematologic cancer	6.67e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JAK2—hematologic cancer	6.66e-06	1.46e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—hematologic cancer	6.62e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MDM2—hematologic cancer	6.62e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2—hematologic cancer	6.6e-06	1.45e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1B—hematologic cancer	6.55e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IFNG—hematologic cancer	6.54e-06	1.44e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MDM2—hematologic cancer	6.5e-06	1.43e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—hematologic cancer	6.49e-06	1.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—IL6—hematologic cancer	6.47e-06	1.42e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CB—hematologic cancer	6.44e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MTOR—hematologic cancer	6.44e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1B—hematologic cancer	6.43e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CD4—hematologic cancer	6.43e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGFR3—hematologic cancer	6.41e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2RA—hematologic cancer	6.41e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—hematologic cancer	6.41e-06	1.41e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—hematologic cancer	6.36e-06	1.4e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK14—hematologic cancer	6.35e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TERT—hematologic cancer	6.34e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MTOR—hematologic cancer	6.33e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CB—hematologic cancer	6.33e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD4—hematologic cancer	6.31e-06	1.39e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—JUN—hematologic cancer	6.23e-06	1.37e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—ESR1—hematologic cancer	6.23e-06	1.37e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	6.19e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PDGFB—hematologic cancer	6.18e-06	1.36e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FN1—hematologic cancer	6.15e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—hematologic cancer	6.13e-06	1.35e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BAD—hematologic cancer	6.08e-06	1.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NFKBIA—hematologic cancer	6.08e-06	1.34e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1B—hematologic cancer	6.05e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TSC2—hematologic cancer	6.04e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDKN1A—hematologic cancer	6.04e-06	1.33e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—hematologic cancer	6.03e-06	1.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH1—hematologic cancer	6.02e-06	1.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—hematologic cancer	5.97e-06	1.31e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1B—hematologic cancer	5.94e-06	1.3e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	5.91e-06	1.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK8—hematologic cancer	5.9e-06	1.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CD80—hematologic cancer	5.9e-06	1.3e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KIT—hematologic cancer	5.89e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CG—hematologic cancer	5.89e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—hematologic cancer	5.88e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—IL6—hematologic cancer	5.86e-06	1.29e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1B—hematologic cancer	5.83e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGFR3—hematologic cancer	5.81e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—hematologic cancer	5.81e-06	1.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTPN11—hematologic cancer	5.78e-06	1.27e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK14—hematologic cancer	5.76e-06	1.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EP300—hematologic cancer	5.75e-06	1.26e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—hematologic cancer	5.73e-06	1.26e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—JUN—hematologic cancer	5.65e-06	1.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—ESR1—hematologic cancer	5.65e-06	1.24e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CREB1—hematologic cancer	5.6e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—SRC—hematologic cancer	5.59e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—CDKN1A—hematologic cancer	5.58e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FN1—hematologic cancer	5.58e-06	1.23e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—hematologic cancer	5.57e-06	1.22e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—BRAF—hematologic cancer	5.53e-06	1.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BAD—hematologic cancer	5.51e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NFKBIA—hematologic cancer	5.51e-06	1.21e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCL2—hematologic cancer	5.48e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDKN1A—hematologic cancer	5.48e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	5.48e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—hematologic cancer	5.47e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6R—hematologic cancer	5.47e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH1—hematologic cancer	5.46e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CREBBP—hematologic cancer	5.46e-06	1.2e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—hematologic cancer	5.41e-06	1.19e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—hematologic cancer	5.39e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—NRAS—hematologic cancer	5.38e-06	1.18e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK8—hematologic cancer	5.35e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CD80—hematologic cancer	5.35e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CG—hematologic cancer	5.34e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KIT—hematologic cancer	5.34e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EP300—hematologic cancer	5.31e-06	1.17e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTPN11—hematologic cancer	5.24e-06	1.15e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EP300—hematologic cancer	5.21e-06	1.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAP2K1—hematologic cancer	5.21e-06	1.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—hematologic cancer	5.19e-06	1.14e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	5.19e-06	1.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CD—hematologic cancer	5.18e-06	1.14e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—SRC—hematologic cancer	5.16e-06	1.13e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK3—hematologic cancer	5.15e-06	1.13e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—ALB—hematologic cancer	5.12e-06	1.13e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CREB1—hematologic cancer	5.08e-06	1.12e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—SRC—hematologic cancer	5.07e-06	1.11e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—BRAF—hematologic cancer	5.02e-06	1.1e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—hematologic cancer	4.98e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCL2—hematologic cancer	4.97e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NRAS—hematologic cancer	4.97e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6R—hematologic cancer	4.96e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—FGF2—hematologic cancer	4.96e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CREBBP—hematologic cancer	4.95e-06	1.09e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	4.9e-06	1.08e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—hematologic cancer	4.89e-06	1.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3R1—hematologic cancer	4.89e-06	1.07e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—NRAS—hematologic cancer	4.88e-06	1.07e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK3—hematologic cancer	4.76e-06	1.04e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JAK2—hematologic cancer	4.75e-06	1.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAP2K1—hematologic cancer	4.72e-06	1.04e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CD—hematologic cancer	4.69e-06	1.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK3—hematologic cancer	4.67e-06	1.03e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MDM2—hematologic cancer	4.64e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—KRAS—hematologic cancer	4.63e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MYC—hematologic cancer	4.63e-06	1.02e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—TGFB1—hematologic cancer	4.61e-06	1.01e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	4.53e-06	9.94e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CB—hematologic cancer	4.51e-06	9.91e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MTOR—hematologic cancer	4.51e-06	9.91e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—FGF2—hematologic cancer	4.49e-06	9.87e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3R1—hematologic cancer	4.43e-06	9.73e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JAK2—hematologic cancer	4.31e-06	9.46e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—KRAS—hematologic cancer	4.27e-06	9.39e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—hematologic cancer	4.25e-06	9.34e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1B—hematologic cancer	4.23e-06	9.3e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MDM2—hematologic cancer	4.2e-06	9.23e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KRAS—hematologic cancer	4.2e-06	9.22e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CASP3—hematologic cancer	4.15e-06	9.11e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—hematologic cancer	4.14e-06	9.1e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MTOR—hematologic cancer	4.09e-06	8.98e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CB—hematologic cancer	4.09e-06	8.98e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—hematologic cancer	4.04e-06	8.87e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—JUN—hematologic cancer	4.03e-06	8.85e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—hematologic cancer	3.94e-06	8.64e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—hematologic cancer	3.93e-06	8.63e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—hematologic cancer	3.91e-06	8.59e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CDKN1A—hematologic cancer	3.91e-06	8.58e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—hematologic cancer	3.9e-06	8.56e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—hematologic cancer	3.86e-06	8.47e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1B—hematologic cancer	3.84e-06	8.43e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK8—hematologic cancer	3.81e-06	8.38e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL6—hematologic cancer	3.77e-06	8.27e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CASP3—hematologic cancer	3.76e-06	8.26e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—hematologic cancer	3.76e-06	8.25e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—EP300—hematologic cancer	3.73e-06	8.19e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EP300—hematologic cancer	3.72e-06	8.16e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—hematologic cancer	3.66e-06	8.04e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—JUN—hematologic cancer	3.65e-06	8.03e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—hematologic cancer	3.63e-06	7.98e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—SRC—hematologic cancer	3.61e-06	7.94e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—hematologic cancer	3.57e-06	7.84e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CDKN1A—hematologic cancer	3.54e-06	7.78e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—hematologic cancer	3.53e-06	7.76e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—hematologic cancer	3.52e-06	7.73e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—hematologic cancer	3.49e-06	7.66e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NRAS—hematologic cancer	3.48e-06	7.64e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—IL6—hematologic cancer	3.48e-06	7.64e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—hematologic cancer	3.47e-06	7.63e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK8—hematologic cancer	3.46e-06	7.59e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL6—hematologic cancer	3.42e-06	7.5e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EP300—hematologic cancer	3.37e-06	7.4e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK3—hematologic cancer	3.33e-06	7.32e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—SRC—hematologic cancer	3.28e-06	7.2e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MYC—hematologic cancer	3.24e-06	7.11e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TGFB1—hematologic cancer	3.23e-06	7.1e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—hematologic cancer	3.21e-06	7.05e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—hematologic cancer	3.19e-06	7.01e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—hematologic cancer	3.16e-06	6.94e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NRAS—hematologic cancer	3.15e-06	6.93e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—hematologic cancer	3.15e-06	6.92e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK3—hematologic cancer	3.02e-06	6.63e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KRAS—hematologic cancer	2.99e-06	6.57e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MYC—hematologic cancer	2.94e-06	6.45e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TGFB1—hematologic cancer	2.93e-06	6.44e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	2.76e-06	6.06e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—hematologic cancer	2.75e-06	6.04e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KRAS—hematologic cancer	2.71e-06	5.96e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—hematologic cancer	2.66e-06	5.84e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—hematologic cancer	2.54e-06	5.59e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—hematologic cancer	2.49e-06	5.48e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL6—hematologic cancer	2.44e-06	5.35e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—hematologic cancer	2.41e-06	5.3e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—hematologic cancer	2.31e-06	5.07e-06	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—hematologic cancer	2.25e-06	4.95e-06	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—hematologic cancer	2.25e-06	4.93e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL6—hematologic cancer	2.21e-06	4.85e-06	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—hematologic cancer	2.04e-06	4.47e-06	CbGpPWpGaD
